Clinical Trial Detail

NCT ID NCT02448771
Title A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors Dana-Farber Cancer Institute
Indications

Her2-receptor negative breast cancer

Therapies

Bazedoxifene + Palbociclib

Age Groups: senior adult

Additional content available in CKB BOOST